Unknown

Dataset Information

0

Correction to "Pharmacogenomic Next-Generation DNA Sequencing: Lessons from the Identification and Functional Characterization of Variants of Unknown Significance in CYP2C9 and CYP2C19".

ABSTRACT:

SUBMITTER:  

PROVIDER: S-EPMC6964146 | biostudies-literature | 2020 Feb

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Correction to "Pharmacogenomic Next-Generation DNA Sequencing: Lessons from the Identification and Functional Characterization of Variants of Unknown Significance in <i>CYP2C9</i> and <i>CYP2C19</i>".

Drug metabolism and disposition: the biological fate of chemicals 20200201 2

Similar Datasets

Unknown Pharmacogenomic Next-Generation DNA Sequencing: Lessons from the Identification and Functional Characterization of Variants of Unknown Significance in <i>CYP2C9</i> and <i>CYP2C19</i>.
| S-EPMC6423619 | biostudies-literature
Unknown Large next-generation sequencing gene panels in genetic heart disease: yield of pathogenic variants and variants of unknown significance.
| S-EPMC6533346 | biostudies-literature
Unknown CYP2C8, CYP2C9, and CYP2C19 Characterization Using Next-Generation Sequencing and Haplotype Analysis: A GeT-RM Collaborative Project.
| S-EPMC9069873 | biostudies-literature
Unknown Analysis of population-specific pharmacogenomic variants using next-generation sequencing data.
| S-EPMC5583360 | biostudies-literature
Unknown Next-Generation Sequencing Gene Panels in Inheritable Cardiomyopathies and Channelopathies: Prevalence of Pathogenic Variants and Variants of Unknown Significance in Uncommon Genes.
| S-EPMC9599286 | biostudies-literature
Unknown Next Generation Sequencing Reveals High Prevalence of BRCA1 and BRCA2 Variants of Unknown Significance in Early-Onset Breast Cancer in African American Women.
| S-EPMC5398176 | biostudies-literature
Unknown CYP2C9 and CYP2C19: Deep Mutational Scanning and Functional Characterization of Genomic Missense Variants.
| S-EPMC7359949 | biostudies-literature
Unknown BRCA1 and BRCA2 Testing through Next Generation Sequencing in a Small Cohort of Italian Breast/Ovarian Cancer Patients: Novel Pathogenic and Unknown Clinical Significance Variants.
| S-EPMC6678297 | biostudies-literature
Unknown Interpretation of genetic testing: variants of unknown significance.
| S-EPMC3587691 | biostudies-literature
Unknown Clinical significance of TP53 variants as possible secondary findings in tumor-only next-generation sequencing.
| S-EPMC6917569 | biostudies-literature